These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3296861

  • 41. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 42. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M, Albiani B, Ricci M, Russo F.
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
    Crowder JE, Cohn JB, Savitsky JP, Morgan DL, Slywka J, Cobert BL, Hryniewicki SW, Piccirillo RT, Wilcox CS.
    Angiology; 1989 Sep; 40(9):795-802. PubMed ID: 2669564
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G, Trübestein R, Ludwig M.
    Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437
    [Abstract] [Full Text] [Related]

  • 47. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A.
    Ann Vasc Surg; 2008 Dec 20; 22(4):552-8. PubMed ID: 18502605
    [Abstract] [Full Text] [Related]

  • 48. Clinical trial of brinase and anticoagulants as a method of treatment for advanced limb ischemia.
    Verhaeghe R, Verstraete M, Schetz J, Vanhove P, Suy R, Vermylen J.
    Eur J Clin Pharmacol; 1979 Sep 20; 16(3):165-70. PubMed ID: 387420
    [Abstract] [Full Text] [Related]

  • 49. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases].
    Hess H, Franke I, Jauch M.
    Fortschr Med; 1973 Jun 14; 91(17):743-8. PubMed ID: 4577522
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.
    Heidrich H, Allenberg J, Cachovan M, Creutzig A, Diehm C, Gruss J, Kriessmann A, Rieger H, Rudofsky G, Trampisch HJ.
    Vasa; 1992 Jun 14; 21(4):333-43. PubMed ID: 1485465
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK, Chopra KL, Aggarwal KK, Parashar SK.
    Indian Heart J; 1989 Jun 14; 41(2):127-33. PubMed ID: 2744799
    [Abstract] [Full Text] [Related]

  • 56. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities.
    Vicari E, Malaguarnera M, La Vignera S, Calzavara F, Battiato C, Calogero AE.
    Asian J Androl; 2008 Nov 14; 10(6):847-53. PubMed ID: 18958348
    [Abstract] [Full Text] [Related]

  • 57. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    Warfarin Antiplatelet Vascular Evaluation Trial InvestigatorsMcMaster University, Hamilton, ON, Canada. anands@mcmaster.ca, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G.
    N Engl J Med; 2007 Jul 19; 357(3):217-27. PubMed ID: 17634457
    [Abstract] [Full Text] [Related]

  • 58. [Effect of ticlopidine on peripheral obliterating arteriopathy].
    Stiegler H, Hess H, Mietaschk A, Trampisch HJ, Ingrisch H.
    Dtsch Med Wochenschr; 1984 Aug 17; 109(33):1240-3. PubMed ID: 6381015
    [Abstract] [Full Text] [Related]

  • 59. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
    Kiesewetter H, Blume J, Bulling B, Gerhards M, Jung F, Radtke H, Franke RP.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1844-7. PubMed ID: 6209081
    [Abstract] [Full Text] [Related]

  • 60. [The use of pentoxyphylline in the treatment of patients with chronic obliterative diseases of lower limb arteries].
    Koshkin VM.
    Angiol Sosud Khir; 2005 Nov 30; 11(4):141-7. PubMed ID: 16474301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.